Back
Syndax Pharmaceuticals Vs. Incyte Industry Stock Comparison
Sell
40
SNDX
Syndax Pharmaceuticals
Last Price:
18.42
Seasonality Move:
-8.74%
Buy
52
INCY
Incyte
Last Price:
65.40
Seasonality Move:
10.85%
Sell
40
Syndax Pharmaceuticals (SNDX)
is a Sell
Is Syndax Pharmaceuticals a Buy, Sell or Hold?
- The current Syndax Pharmaceuticals [SNDX] share price is $18.63. The Score for SNDX is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- SNDX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
52
Incyte (INCY)
is a Buy
Is Incyte a Buy, Sell or Hold?
- The current Incyte [INCY] share price is $66.85. The Score for INCY is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
- INCY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
SNDX Stock Price Chart
What is Syndax Pharmaceuticals's stock price today?
-
The Syndax Pharmaceuticals share price today is $18.63
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SNDX is experiencing slight buying pressure.
INCY Stock Price Chart
SNDX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.68 | Sell |
| Relative Strength Index (14 RSI): | 41.97 | Sell |
| Chaikin Money Flow: | 473332 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (18.62 - 20.58) | Sell |
| Bollinger Bands (100): | (19.16 - 22.32) | Sell |
INCY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.55 | Buy |
| Relative Strength Index (14 RSI): | 60.72 | Buy |
| Chaikin Money Flow: | 1264499 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (62.66 - 65.82) | Buy |
| Bollinger Bands (100): | (57.17 - 65.25) | Buy |
SNDX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 18.39 | Buy |
| 20-day SMA: | 19.44 | Sell |
| 50-day SMA: | 20.88 | Sell |
| 200-day SMA: | 21.19 | Sell |
| 8-day EMA: | 18.53 | Buy |
| 20-day EMA: | 19.18 | Sell |
| 50-day EMA: | 20.08 | Sell |
| 200-day EMA: | 20.56 | Sell |
INCY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 64.76 | Buy |
| 20-day SMA: | 64.52 | Buy |
| 50-day SMA: | 64.26 | Buy |
| 200-day SMA: | 60 | Buy |
| 8-day EMA: | 65.19 | Buy |
| 20-day EMA: | 64.48 | Buy |
| 50-day EMA: | 63.53 | Buy |
| 200-day EMA: | 61.27 | Buy |
Syndax Pharmaceuticals Earnings Growth & SNDX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.34 per share, an increase next quarter of $0.24 per share, a decrease this year of $0.79 per share, and an increase next year of $0.54 per share.
Incyte Earnings Growth & INCY Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.28 per share, an increase next quarter of $0.16 per share, a decrease this year of $2.06 per share, and an increase next year of $4.38 per share.
Syndax Pharmaceuticals Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Incyte Technical Analysis
| Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | Sep 19 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||